YOUR SEARCH FOR Text 262 RESULTS
241 of Total
Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs
242 of Total
Incyte Reports 2024 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
243 of Total
Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
244 of Total
Incyte Reports 2024 Fourth Quarter and Year-End Financial Results, Provides 2025 Financial Guidance
245 of Total
Incyte Reports 2025 First Quarter Financial Results and Provides Updates on Key Clinical Programs
246 of Total
Incyte Reports 2025 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
247 of Total
Incyte Reports Third Quarter 2025 Financial Results and Provides Business Updates
248 of Total
Incyte Announces Positive Topline Results from Pivotal Study of Tafasitamab (Monjuvi®/Minjuvi®) as a
250 of Total
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advance